Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-4-14
pubmed:abstractText
SHIP-1 (SH2 (Src homology 2)-containing inositol 5'-phosphatase-1) functions as a negative regulator of immune responses by hydrolyzing phosphatidylinositol-3,4,5-triphosphate generated by phosphoinositide-3 (PI 3)-kinase activity. As a result, SHIP-1 deficiency in mice results in myeloproliferation and B-cell lymphoma. On the other hand, SHIP-1-deficient mice have a reduced T-cell population, but the underlying mechanisms are unknown. In this work, we hypothesized that SHIP-1 plays anti-apoptotic functions in T cells upon stimulation of the death receptor CD95/APO-1/Fas. Using primary T cells from SHIP-1(-/-) mice and T leukemic cell lines, we report that SHIP-1 is a potent inhibitor of CD95-induced death. We observed that a small fraction of the SHIP-1 pool is localized to the endoplasmic reticulum (ER), in which it promotes CD95 glycosylation. This post-translational modification requires an intact SH2 domain of SHIP-1, but is independent of its phosphatase activity. The glycosylated CD95 fails to oligomerize upon stimulation, resulting in impaired death-inducing signaling complex (DISC) formation and downstream apoptotic cascade. These results uncover an unanticipated inhibitory function for SHIP-1 and emphasize the role of glycosylation in the regulation of CD95 signaling in T cells. This work may also provide a new basis for therapeutic strategies using compounds inducing apoptosis through the CD95 pathway on SHIP-1-negative leukemic T cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1476-5551
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
821-32
pubmed:meshHeading
pubmed-meshheading:20147977-Animals, pubmed-meshheading:20147977-Antigens, CD95, pubmed-meshheading:20147977-Apoptosis, pubmed-meshheading:20147977-Blotting, Western, pubmed-meshheading:20147977-Cells, Cultured, pubmed-meshheading:20147977-Death Domain Receptor Signaling Adaptor Proteins, pubmed-meshheading:20147977-Endoplasmic Reticulum, pubmed-meshheading:20147977-Flow Cytometry, pubmed-meshheading:20147977-Glycosylation, pubmed-meshheading:20147977-Humans, pubmed-meshheading:20147977-Lymphoma, T-Cell, pubmed-meshheading:20147977-Mice, pubmed-meshheading:20147977-Mice, Knockout, pubmed-meshheading:20147977-Phosphoric Monoester Hydrolases, pubmed-meshheading:20147977-Phosphorylation, pubmed-meshheading:20147977-Protein Processing, Post-Translational, pubmed-meshheading:20147977-RNA, Small Interfering, pubmed-meshheading:20147977-Signal Transduction, pubmed-meshheading:20147977-T-Lymphocytes
pubmed:year
2010
pubmed:articleTitle
SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity.
pubmed:affiliation
Grappe Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-Research, Signal Transduction Unit, Faculty of Sciences, University of Liège, Liège, Belgium.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't